Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV6 | Q9H1D0 | 4/20 | 0.63 |
| ▸ | ORAI1 | Q96D31 | 3/20 | 0.63 |
| ▸ | ORAI2 | Q96SN7 | 3/20 | 0.63 |
| ▸ | ORAI3 | Q9BRQ5 | 3/20 | 0.63 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.63 |
| ▸ | CA4 | P22748 | 3/20 | 0.55 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.55 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.55 |
| ▸ | CA6 | P23280 | 1/20 | 0.55 |
| ▸ | CA5A | P35218 | 1/20 | 0.55 |
| ▸ | CA7 | P43166 | 1/20 | 0.55 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 5/20 | 0.41 |
| ▸ | CA2 | P00918 | 4/20 | 0.41 |
| ▸ | MGLL | Q99685 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28696473 | 0.89 | TRPV6 (0.57) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL28610015 | 0.86 | TRPV6 (0.56) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL263598 | 0.80 | TRPV6 (0.52) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL28718291 | 0.80 | TRPV6 (0.52) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL244920 | 0.78 | TRPV6 (0.50) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL9362337 | 0.78 | ENPP2 (0.50) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL7908605 | 0.78 | TRPV6 (0.50) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL184420 | 0.78 | TRPV6 (0.50) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL56106 | 0.78 | TRPV6 (0.50) | TRPV6ORAI1ORAI2ORAI3PCSK9 | |
| SCHEMBL1845171 | 0.78 | TRPV6 (0.50) | TRPV6ORAI1ORAI2ORAI3PCSK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 144 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122068122-A | Electrolyte and lithium ion battery | 珠海冠宇电池股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-119898793-A | Dealkylation method, transalkylation method, hydrogenation method, boron-containing molecular sieve, preparation method and application thereof | 中国石油化工股份有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-117603044-B | Method for depolymerizing and upgrading polyester into carboxylate and borate by using ionic liquid to catalyze | 浙江大学 | 2025-03-07 | — | — | CN | claimed |
| CN-117585671-A | Preparation method of gradient graphitized anode material | 浙江南都电源动力股份有限公司 | 2024-02-23 | — | — | CN | claimed |
| CN-117088776-A | Method for preparing 2-nitrobiphenyl compound | 江西天宇化工有限公司 | 2023-11-21 | — | — | CN | claimed |
| CN-117088777-A | Method for preparing 2-nitrobiphenyl compound | 南通泰禾化工股份有限公司 | 2023-11-21 | — | — | CN | claimed |
| US-11339249-B2 | Compound having fluorene skeleton, and method for manufacturing same | TEIJIN LIMITED (JP) | 2022-05-24 | — | — | US | claimed |
| CN-114507305-A | Method for synthesizing zirconocene type olefin polymerization catalyst | 吉林大学 | 2022-05-17 | — | — | CN | claimed |
| CN-114478500-A | Coumarin two-photon initiator and synthesis method and application thereof | 浙江大学 | 2022-05-13 | — | — | CN | claimed |
| CN-108203434-B | Asymmetric synthesis method for preparing solifenacin | 中国科学院上海药物研究所 | 2022-02-25 | — | — | CN | claimed |
| CN-108219431-B | Polycarbonate resin molding material | 出光兴产株式会社 | 2021-12-24 | — | — | CN | claimed |
| CN-111293358-B | Lithium ion battery electrolyte and lithium ion battery | 张家港市国泰华荣化工新材料有限公司 | 2021-07-13 | — | — | CN | claimed |
| EP-3747856-A1 | COMPOUND HAVING FLUORENE SKELETON, AND METHOD FOR MANUFACTURING SAME | Teijin Limited (JP) | 2020-12-09 | — | — | EP | claimed |
| US-20200354517-A1 | COMPOUND HAVING FLUORENE SKELETON, AND METHOD FOR MANUFACTURING SAME | TEIJIN LIMITED (JP) | 2020-11-12 | — | — | US | claimed |
| CN-111465589-A | Compound having fluorene skeleton and method for producing same | 帝人株式会社 | 2020-07-28 | — | — | CN | claimed |
| CN-111293358-A | Lithium ion battery electrolyte and lithium ion battery | 张家港市国泰华荣化工新材料有限公司 | 2020-06-16 | — | — | CN | claimed |
| CN-111211354-A | High-voltage lithium ion battery combined electrolyte additive, electrolyte and battery thereof | 松山湖材料实验室 | 2020-05-29 | — | — | CN | claimed |
| US-20150315324-A1 | TERMINAL BORINIC ACID GROUP-MODIFIED POLYMER, METHOD OF MANUFACTURING THE SAME AND RUBBER COMPOSITION CONTAINING THE SAME | THE YOKOHAMA RUBBER CO., LTD. (JP) | 2015-11-05 | — | — | US | claimed |
| CN-117886736-B | 2-Indolyl-3-imine indoline derivative, preparation method and application thereof | Suzhou Highfine Biotech Co.,Ltd. (CN) | 2026-05-26 | — | — | CN | disclosed |
| EP-0037582-A2 | Process for preparing 1,2-diacyl-SN-glycerols | KSV-Chemicals Oy (FI) | 1981-10-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200354517-A1 | COMPOUND HAVING FLUORENE SKELETON, AND METHOD FOR MANUFACTURING SAME | RFT1, AFF1, RER1 | TRPV6 2606/4885ORAI1 4171/4885ORAI2 1615/4885 |
| US-11339249-B2 | Compound having fluorene skeleton, and method for manufacturing same | RFT1, AFF1, RER1 | TRPV6 2606/4885ORAI1 4171/4885ORAI2 1615/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.